Veeda is managing the study of Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine Check out our Assay List (Method Library) Our latest article on the Development and Execution of In Vivo Bioassays


The growing prominence of Tyrosine Kinase Inhibitors (TKIs) and its Bioequivalence Studies

Stereo-isomeric drugs and Bioanalysis

Long-Acting Injectable Antipsychotics

Regulatory & Pharmacovigilance Considerations for NCEs

India's Resurgence as a Clinical Trial Destination

Approaches used in Replicate Bioequivalence Studies

First in Man Studies – Strategies for a Successful Outcome.

Population Bioequivalence for In-Vitro Studies.

Request for Proposal

Submit your details and we’ll be in touch shortly. You can also email us if you would prefer.